See more : Innovative Eyewear, Inc. (LUCY) Income Statement Analysis – Financial Results
Complete financial analysis of Danone S.A. (DANOY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danone S.A., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Ovoca Bio plc (OVXA.IR) Income Statement Analysis – Financial Results
- Ajanta Pharma Limited (AJANTPHARM.BO) Income Statement Analysis – Financial Results
- Atacadão S.A. (CRFB3.SA) Income Statement Analysis – Financial Results
- SC Asset Corporation Public Company Limited (SC-R.BK) Income Statement Analysis – Financial Results
- Carawine Resources Limited (CWX.AX) Income Statement Analysis – Financial Results
Danone S.A. (DANOY)
About Danone S.A.
Danone S.A. operates in the food and beverage industry in Europe, Noram, Latin America, the Asia Pacific, Africa, and the Middle East. The company operates through three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. It produces and distributes yogurts; milk products; coffee creamers, drinks, and beverages; plant-based products; and ice creams, desserts, and nutritional powdered protein products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, as well as under the licensed brands, including International Delight, Dunkin' Donuts, and Bailey's. The company also offers specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics brands. In addition, it provides tube feeding products under the Nutrison name; oral nutritional supplements under the Fortimel and NutriDrink names; and hypoallergenic products for children with allergies primarily under the Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo names. Further, the company offers water with natural fruit extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 27.62B | 27.66B | 24.28B | 23.62B | 25.29B | 24.65B | 24.68B | 21.94B | 22.41B | 21.14B | 21.30B | 20.87B | 19.32B | 17.01B | 14.98B | 15.22B | 12.78B | 14.07B | 13.01B | 13.69B | 13.11B | 13.57B | 14.50B | 14.33B | 13.33B | 12.92B | 13.35B |
Cost of Revenue | 14.54B | 14.92B | 12.76B | 12.27B | 12.88B | 12.73B | 12.46B | 10.74B | 11.21B | 11.06B | 10.98B | 10.41B | 9.54B | 7.96B | 6.75B | 7.17B | 6.38B | 7.21B | 6.64B | 6.36B | 5.97B | 6.45B | 7.43B | 7.23B | 6.04B | 6.10B | 6.66B |
Gross Profit | 13.08B | 12.74B | 11.52B | 11.35B | 12.41B | 11.92B | 12.22B | 11.20B | 11.20B | 10.09B | 10.32B | 10.46B | 9.78B | 9.05B | 8.23B | 8.05B | 6.40B | 6.86B | 6.38B | 7.33B | 7.14B | 7.12B | 7.07B | 7.10B | 7.29B | 6.82B | 6.69B |
Gross Profit Ratio | 47.37% | 46.05% | 47.45% | 48.07% | 49.07% | 48.36% | 49.51% | 51.04% | 49.97% | 47.71% | 48.46% | 50.12% | 50.61% | 53.21% | 54.95% | 52.88% | 50.06% | 48.74% | 48.99% | 53.51% | 54.43% | 52.48% | 48.75% | 49.54% | 54.71% | 52.81% | 50.10% |
Research & Development | 398.00M | 339.00M | 338.00M | 323.00M | 351.00M | 335.00M | 342.00M | 333.00M | 307.00M | 272.00M | 275.00M | 257.00M | 233.00M | 209.00M | 206.00M | 198.00M | 121.00M | 126.00M | 123.27M | 130.57M | 129.43M | 133.42M | 125.88M | 125.64M | 122.24M | 120.14M | 114.36M |
General & Administrative | 2.75B | 2.64B | 2.33B | 2.29B | 2.39B | 2.22B | 2.23B | 2.00B | 1.94B | 1.74B | 1.71B | 1.75B | 1.56B | 1.49B | 1.36B | 1.30B | 943.00M | 1.05B | 4.34B | 5.29B | 5.14B | 5.14B | 5.33B | 5.42B | 5.02B | 4.50B | 4.41B |
Selling & Marketing | 6.29B | 6.29B | 5.52B | 5.37B | 5.77B | 5.64B | 5.89B | 5.56B | 5.68B | 5.21B | 5.43B | 5.47B | 5.09B | 4.66B | 4.21B | 4.20B | 3.50B | 3.61B | -3.11B | 3.11B | -4.33B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.04B | 8.93B | 7.84B | 7.65B | 8.16B | 7.86B | 8.12B | 7.57B | 7.62B | 6.95B | 7.13B | 7.22B | 5.09B | 6.16B | 5.57B | 5.49B | 4.44B | 4.65B | 4.34B | 5.29B | 5.14B | 5.14B | 5.33B | 5.42B | 5.02B | 4.50B | 4.41B |
Other Expenses | 1.61B | 53.00M | 39.00M | 44.00M | 95.00M | 60.00M | 62.00M | -23.00M | -64.00M | -16.00M | -221.00M | -6.00M | 67.00M | 107.00M | -77.00M | 169.00M | 288.00M | 135.00M | 202.63M | -239.01M | -227.09M | 264.93M | -654.12M | 59.63M | 760.25M | 701.14M | 728.27M |
Operating Expenses | 11.04B | 9.32B | 8.22B | 8.02B | 8.60B | 9.23B | 8.49B | 8.22B | 8.21B | 7.46B | 7.47B | 7.54B | 7.05B | 6.47B | 5.94B | 5.86B | 4.85B | 4.91B | 4.67B | 5.62B | 5.53B | 5.53B | 5.45B | 5.54B | 5.90B | 5.32B | 5.26B |
Cost & Expenses | 25.58B | 24.25B | 20.98B | 20.29B | 21.48B | 21.95B | 20.95B | 18.96B | 19.42B | 18.52B | 18.45B | 17.94B | 16.59B | 14.43B | 12.69B | 13.03B | 11.23B | 12.13B | 11.31B | 11.99B | 11.51B | 11.98B | 12.88B | 12.77B | 11.94B | 11.42B | 11.92B |
Interest Income | 156.00M | 155.00M | 156.00M | 151.00M | 181.00M | 162.00M | 151.00M | 130.00M | 122.00M | 94.00M | 76.00M | 75.00M | 67.00M | 87.00M | 76.00M | 58.00M | 132.00M | 182.00M | 88.00M | 55.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 513.00M | 308.00M | 323.00M | 358.00M | 400.00M | 393.00M | 414.00M | 276.00M | 274.00M | 274.00M | 269.00M | 245.00M | 241.00M | 230.00M | 264.00M | 497.00M | 307.00M | 219.00M | 189.00M | 149.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.61B | 1.86B | 1.27B | 1.45B | 1.39B | 863.00M | 830.00M | 754.00M | 1.22B | 956.00M | 710.00M | 670.00M | -46.00M | 594.00M | 549.00M | 525.00M | 420.00M | 491.00M | 477.88M | 558.42M | 597.90M | 721.40M | 778.87M | 759.16M | 760.25M | 701.14M | 728.27M |
EBITDA | 3.81B | 4.00B | 3.58B | 4.30B | 4.65B | 4.39B | 4.68B | 3.69B | 3.42B | 3.07B | 3.47B | 3.36B | 3.31B | 2.52B | 2.91B | 2.57B | 2.10B | 2.52B | 2.26B | 2.20B | 2.20B | 2.31B | 2.39B | 2.31B | 2.16B | 2.21B | 2.16B |
EBITDA Ratio | 13.79% | 18.36% | 19.18% | 20.41% | 20.69% | 17.85% | 19.21% | 16.98% | 18.44% | 16.70% | 15.25% | 16.26% | 14.13% | 19.48% | 18.92% | 17.25% | 16.41% | 18.39% | 16.77% | 16.53% | 16.78% | 17.05% | 16.49% | 16.15% | 16.17% | 17.07% | 16.18% |
Operating Income | 2.04B | 3.22B | 3.39B | 2.80B | 3.24B | 2.74B | 3.73B | 2.92B | 2.21B | 2.15B | 2.13B | 2.75B | 2.73B | 2.58B | 2.51B | 2.19B | 1.55B | 1.87B | 1.70B | 1.70B | 1.60B | 1.59B | 1.61B | 1.55B | 1.40B | 1.50B | 1.43B |
Operating Income Ratio | 7.39% | 11.62% | 13.97% | 11.85% | 12.80% | 11.12% | 15.13% | 13.32% | 9.86% | 10.17% | 9.99% | 13.16% | 14.13% | 15.16% | 16.76% | 14.37% | 12.10% | 13.32% | 13.10% | 12.45% | 12.22% | 11.73% | 11.12% | 10.85% | 10.47% | 11.64% | 10.73% |
Total Other Income/Expenses | -321.00M | -311.00M | -262.00M | -310.00M | -370.00M | -348.00M | -437.00M | -293.00M | -285.00M | -312.00M | -263.00M | -329.00M | -294.00M | -20.00M | -489.00M | -584.00M | -177.00M | -68.00M | -110.00M | -33.48M | -276.32M | 183.92M | -1.06B | -268.31M | -210.68M | -473.91M | -432.64M |
Income Before Tax | 1.72B | 1.83B | 2.00B | 2.49B | 2.87B | 2.39B | 3.30B | 2.63B | 1.93B | 1.84B | 1.87B | 2.45B | 2.44B | 2.49B | 2.02B | 1.60B | 1.37B | 1.81B | 1.59B | 1.53B | 1.33B | 1.78B | 549.59M | 1.29B | 1.18B | 1.03B | 999.91M |
Income Before Tax Ratio | 6.23% | 6.62% | 8.22% | 10.53% | 11.34% | 9.71% | 13.36% | 11.99% | 8.59% | 8.70% | 8.76% | 11.72% | 12.60% | 14.63% | 13.50% | 10.53% | 10.72% | 12.83% | 12.26% | 11.14% | 10.11% | 13.09% | 3.79% | 8.98% | 8.89% | 7.97% | 7.49% |
Income Tax Expense | 768.00M | 778.00M | 589.00M | 762.00M | 793.00M | 716.00M | 842.00M | 804.00M | 626.00M | 599.00M | 604.00M | 712.00M | 626.00M | 576.00M | 424.00M | 443.00M | 410.00M | 360.00M | 472.81M | 456.62M | 487.53M | 490.78M | 416.97M | 563.25M | 500.87M | 432.98M | 447.00M |
Net Income | 881.00M | 959.00M | 1.41B | 1.96B | 1.92B | 2.34B | 2.45B | 1.72B | 1.28B | 1.12B | 1.42B | 1.67B | 1.67B | 1.88B | 1.36B | 1.31B | 4.18B | 1.35B | 1.46B | 316.46M | 837.70M | 1.28B | 132.62M | 722.96M | 683.73M | 597.37M | 552.91M |
Net Income Ratio | 3.19% | 3.47% | 5.79% | 8.28% | 7.57% | 9.47% | 9.92% | 7.84% | 5.72% | 5.29% | 6.68% | 8.01% | 8.65% | 11.02% | 9.08% | 8.63% | 32.72% | 9.61% | 11.25% | 2.31% | 6.39% | 9.47% | 0.91% | 5.05% | 5.13% | 4.62% | 4.14% |
EPS | 1.35 | 1.48 | 2.18 | 2.99 | 2.95 | 0.73 | 0.78 | 0.56 | 0.42 | 0.38 | 0.48 | 0.56 | 0.55 | 0.61 | 0.48 | 0.53 | 1.75 | 0.56 | 0.60 | 0.13 | 0.33 | 0.49 | 0.05 | 0.26 | 0.24 | 0.21 | 0.20 |
EPS Diluted | 1.36 | 1.48 | 2.17 | 2.99 | 2.95 | 0.73 | 0.78 | 0.56 | 0.42 | 0.38 | 0.48 | 0.55 | 0.55 | 0.61 | 0.48 | 0.53 | 1.74 | 0.55 | 0.59 | 0.12 | 0.32 | 0.47 | 0.05 | 0.26 | 0.24 | 0.20 | 0.19 |
Weighted Avg Shares Out | 647.79M | 639.05M | 646.16M | 649.33M | 648.25M | 3.21B | 3.13B | 3.08B | 3.05B | 2.97B | 2.94B | 3.00B | 3.01B | 3.07B | 2.83B | 2.46B | 2.38B | 2.43B | 2.46B | 2.51B | 2.55B | 2.64B | 2.79B | 2.81B | 2.79B | 2.80B | 2.83B |
Weighted Avg Shares Out (Dil) | 641.74M | 639.48M | 646.45M | 649.97M | 649.11M | 3.22B | 3.14B | 3.08B | 3.05B | 2.98B | 2.94B | 3.02B | 3.02B | 3.08B | 2.83B | 2.47B | 2.40B | 2.45B | 2.50B | 2.58B | 2.63B | 2.74B | 2.85B | 2.83B | 2.97B | 2.92B | 2.93B |
Lifeway Foods: Growth Opportunities And Support From Danone Make It A Buy
Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and Nutrition
Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform
Danone Joins 100+ Accelerator as Fifth Partner for Scaling Sustainable Startup Innovation
DANONE: Completion by Danone of the sale of its EDP business in Russia
Swander Pace Capital Completes Sale of Functional Formularies to Danone
Danone acquires Functional Formularies
Danone successfully issues a €700 million bond
Danone: 2024 Danone Shareholders' Meeting: approval of all resolutions
KHC or DANOY: Which Is the Better Value Stock Right Now?
Source: https://incomestatements.info
Category: Stock Reports